Current Drug Targets

Papers
(The H4-Index of Current Drug Targets is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Current Research Trends in Cytokine Storm: A Scientometric Study45
Meet the Editorial Board Member37
Cell Entry and Unusual Replication of SARS-CoV-235
Meet the Editorial Board Member34
SARS-Coronavirus 2, A Metabolic Reprogrammer: A Review in the Context of the Possible Therapeutic Strategies33
Polymeric Micelle-Based Nanogels as Emerging Drug Delivery Systems in Breast Cancer Treatment: Promises and Challenges30
Retracted: Meet the Editorial Board Member27
Unfurling the Potential of Antiviral Agents Aimed for RNA Virus Ailment26
The Development of the Combination Drug Leukovir® Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review24
Review on the Drug Intolerance and Vaccine Development for the Leishmaniasis24
The Marburg Virus Outbreak in West Africa23
Metformin: A Promising Antidiabetic Medication for Cancer Treatment22
Meet the Regional Editor22
Antibiotic Adjuvants: A Promising Approach to Combat Multidrug Resistant Bacteria22
Use of Total Parenteral Nutrition (TPN) as a Vehicle for Drug Delivery21
Meet the Editorial Board Member21
Current Perspectives of Healthy Mitochondrial Function for Healthy Neurons20
Envisioning Glucose Transporters (GLUTs and SGLTs) as Novel Intervention against Cancer: Drug Discovery Perspective and Targeting Approach20
Xerostomia: Advances and Challenges in Drug Development20
Venom of Viperidae: A Perspective of its Antibacterial and Antitumor Potential19
Targeted Delivery Strategies of Herbal-Based Nanogels: Advancements and Applications19
Regulation of Tumor Immune Microenvironment by Sphingolipids and Lysophosphatidic Acid19
Targeting Neurodegeneration: The Emerging Role of Hybrid Drugs19
An Updated Review for the Diabetic Wound Healing Systems19
Gamma Secretase Inhibitor: Therapeutic Target via NOTCH Signaling in T Cell Acute Lymphoblastic Leukemia19
0.12641310691833